Filter by: patients
Home > Symptoms and Side Effects Overview > Transplant rejection prevention Report

See More Symptoms

See all 7270 symptoms in the PatientsLikeMe system shared by patients just like you.

Transplant rejection prevention Report

Immunosuppression reduces the activation or efficacy of the immune system. Deliberately induced immunosuppression is generally done to prevent the body from rejecting an organ transplant, treating graft-versus-host disease after a bone marrow transplant, or to treat auto-immune diseases.


What we've learned from patients who report Transplant rejection prevention

Symptom severities

Severe
 3
Moderate
 7
Mild
 10
None
 63

What patients report taking for the purpose of treating Transplant rejection prevention

What patients report taking for the purpose of treating Transplant rejection prevention
Reason # Patients Percentage of patients
Prograf 239   Prograf: 1195%
Prednisone 201   Prednisone: 1005%
Tacrolimus 152   Tacrolimus: 760%
CellCept 151   CellCept: 755%
Mycophenolate 130   Mycophenolate: 650%
Myfortic 61   Myfortic: 305%
Rapamune 47   Rapamune: 235%
Cyclosporine 39   Cyclosporine: 195%
Neoral 36   Neoral: 180%
Azathioprine 20   Azathioprine: 100%
Methylprednisolone 19   Methylprednisolone: 95%
Imuran 18   Imuran: 90%
Sirolimus 17   Sirolimus: 85%
Gengraf 15   Gengraf: 75%
Solu-Medrol Infusion 4   Solu-Medrol Infusion: 20%
Sandimmune 4   Sandimmune: 20%
Prednisolone 4   Prednisolone: 20%
Advagraf 3   Advagraf: 15%
Orencia 2   Orencia: 10%
MS Phase 3 Study Fingolimod FREEDOMS II 2   MS Phase 3 Study Fingolimod FREEDOMS II: 10%
Zenapax 2   Zenapax: 10%
Deltasone 2   Deltasone: 10%
CytoGam 1   CytoGam: 5%
Simulect 1   Simulect: 5%
Wockhardt Methylprednisolone 1   Wockhardt Methylprednisolone: 5%
Encorton 1   Encorton: 5%
Lisinopril 1   Lisinopril: 5%
Certican 1   Certican: 5%
Medications 1   Medications: 5%
Biopsy 1   Biopsy: 5%

Report created on May 21, 2012.